Author

Ben S. Wittner

Harvard UniversityORCID 0000-0001-5657-9849Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Daniel A. HaberiD· 3 shared Ezgi AntmeniD· 3 shared Shyamala MaheswaraniD· 3 shared Aditya BardiaiD· 2 shared David Tsai TingiD· 2 shared Douglas B. FoxiD· 2 shared Douglas Scott MicalizziiD· 2 shared Hunter C. Russell· 2 shared

Activity by Year

2025-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Daniel A. HaberORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyProceedings of the National Academy of SciencesPeer-reviewedAug 6, 2025

The E3 ligase HECTD4 regulates COX-2 dependent tumor progression and metastasis

Joanna A. Vuille, Cem Tanrıöver, Ezgi Antmen…·Daniel A. Haber

The paper identifies HECTD4 as a tumor and metastasis suppressor that targets COX-2 for degradation, with COX-2 stabilization driving pro-tumorigenic effects in breast cancer.

5 citations

humanproteomics

𝕏 PostBluesky

Cancer BiologyProceedings of the National Academy of SciencesPeer-reviewedJul 7, 2025

CDKN1B (p27kip1) enhances drug tolerant persister CTCs by restricting polyploidy following mitotic inhibitors.

E. Philip Horwitz, Taronish D. Dubash, Annamária Szabolcs…·Daniel A. Haber

This study identifies CDKN1B as a regulator of drug-tolerant persister CTCs by preventing polyploidy after mitotic inhibitor treatment in breast cancer.

5 citations

humanbulk RNA-seq

𝕏 PostBluesky

BioengineeringNature CommunicationsPeer-reviewedJan 2, 2025

Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product

Avanish Mishra, Shih‐Bo Huang, Taronish D. Dubash…·Mehmet Toner

This study uses high-throughput microfluidic technology to enrich CTCs from large blood volumes, enabling detailed molecular and morphological analysis of tumor cells in metastatic cancer patients.

62 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky